Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis

European Respiratory Journal

Volumn 25, Issue 6, 2005, Pages 1050-1056

  Moorcroft, A J ^a   Dodd, M E ^b   Morris, J ^b   Webb, A K ^b  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Dyspnoea; Exercise; Lactate; Muscle effort; Symptom limitation

Indexed keywords

CARBON DIOXIDE; LACTIC ACID; OXYGEN;

ADULT; ARTICLE; BICYCLE ERGOMETRY; BODY MASS; BREATHING MUSCLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTIC FIBROSIS; DISEASE SEVERITY; DYSPNEA; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE FACILITY; HEART RATE; HUMAN; LUNG DISEASE; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTION; OXYGEN CONSUMPTION; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SYMPTOM;

ADULT; CYSTIC FIBROSIS; DYSPNEA; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LACTIC ACID; LUNG; MALE; MUSCLE FATIGUE; OXYGEN CONSUMPTION; RESPIRATORY FUNCTION TESTS;

EID: 20444461559     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00011404     Document Type: Article

References (42)

1. Schneiderman-Walker J, Pollock SL, Corey M, et al. A randomised controlled trial of a 3-year home exercise-programme in cystic fibrosis. J Pediatr 2000; 136: 304-310.
2. Moorcroft AJ, Dodd ME, Morris J, Webb AK. Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial. Thorax 2004; 59: 1074-1080.
3. Godfrey S, Mearns M. Pulmonary function and response to exercise in cystic fibrosis. Arch Dis Child 1971; 46: 144-151.
4. Cerny FJ, Pullano TP, Cropp GJ. Cardiorespiratory adaptations to exercise in cystic fibrosis. Am Rev Respir Dis 1982; 126: 217-220.
5. Moorcroft AJ, Dodd ME, Webb AK. Long-term change in exercise capacity, body mass, and pulmonary function in adults with cystic fibrosis. Chest 1997; 111: 338-343.
6. Selvadurai HC, Allen J, Sachinwalla T, et al. Muscle function and resting energy expenditure in female athletes with cystic fibrosis. Am J Respir Crit Care Med 2003; 66: 1476-1480.
7. Moser C, Tirakitsoontorn P, Nussbaum E, Newcomb R, Cooper D. Muscle size and cardiorespiratory response to exercise in cystic fibrosis 2000. Am J Respir Crit Care Med 2000; 162: 1823-1827.
8. Shah AR, Gozal D, Keens, TG. Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Am J Respir Crit Care Med 1988; 157: 1145-1150.
9. Klijn PH, van der Net J, Kimpen JL, Helders PJ, van der Ent CK. Longitudinal determinants of peak anaerobic performance in children with cystic fibrosis. Chest 2003; 124: 2215-2219.
10. Klijn PH, Terheggen-Lagro W, van der Ent CK, van der Net J, Kimpen JL, Helders PJ. Anaerobic exercise in pediatric cystic fibrosis. Pediatr Pulmonol 2003; 36: 223-229.
11. Marcotte JE, Grisdale RK, Levison H, Ceates AL, Canny GJ. Multiple factors limit exercise capacity in cystic fibrosis. Pediatr Pulmonol 1986; 2: 274-281.
12. Coates AL, Boyce P, Muller D, Mearns M, Godfrey S. The role of nutritional status, airway obstruction, hypoxia, and abnormalities in serum lipid composition in limiting exercise tolerance in children with cystic fibrosis. Acta Paediatr Scand 1980; 69: 353-358.
13. Lands LC, Heigenhauser GJ, Jones NL. Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Sci 1991; 83: 391-397.
14. De Meer K, Gulmans VAM, van der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999; 159: 748-754.
15. Myers J, Ashley E. Dangerous curves: a perspective on exercise, lactate and the anaerobic threshold. Chest 1997; 111: 787-795.
16. Hjeltnes N, Stanghelle JK, Skyberg D. Pulmonary function and oxygen uptake during exercise in 16 year old boys with cystic fibrosis. Acta Paediatr Scand 1984; 73: 548-553.
17. Martin D, Day J, Ward G, Carter E, Chesrown S. Effects of breathing a normoxic helium mixture on exercise tolerance of patients with cystic fibrosis. Pediatr Pulmonol 1994; 18: 206-210.
18. McLoughlin P, McKeogh D, Byrne P, Finlay G, Hayes J, FitzGerald MX. Assessment of fitness in patients with cystic fibrosis and mild lung disease. Thorax 1997; 52: 425-430.
19. Nikolaizik WH, Knopfli B, Leister E, de Boer P, Sievers B, Schoni MH. The anaerobic threshold in cystic fibrosis: comparison of V-slope method, lactate turn points, and Conconi test. Pediatr Pulmonol 1998; 25: 147-153.
20. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992; 146: 935-940.
21. Borg GA. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-381.
22. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximum expiratory flow-volume curve with growth and ageing. Am Rev Respir Dis 1983; 127: 725-734.
23. Jones NL. Clinical exercise testing. 3rd Edn. Philadelphia, W.B. Saunders, 1988.
24. Cassaburi R, Patessio A, Iolli F, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis 1991; 143: 9-18.
25. Lebecque P, Lapierre JG, Lamarre A, et al. Diffusion capacity and oxygen desaturation effects on exercise in patients with cystic fibrosis. Chest 1987; 91: 693-697.
26. Maltais F, Jobin J, Sullivan MJ, et al. Metabolic and hemodynamic responses to lower limb during exercise in patients with COPD. J Appl Physiol 1998; 84: 1573-1580.
27. Maltaise F, Simard A, Simard C, Jobin J, Desgognes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996; 153: 288-293.
28. Maltais F, LeBlanc P, Simard C, et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 442-447.
29. Szeinberg A, England S, Mindorff C, Fraser IM, Levison H. Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished young adult male patients with cystic fibrosis. Am Rev Respir Dis 1985; 132: 766-769.
30. de Meer K, Jeneson JA, Gulmans VA, van der Laag J, Berger R. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 1995; 50: 980-983.
31. Dechecchi MC, Girella E, Cabrini G, Berton G. The Km of NADH dehydrogenase is decreased in mitochondria of cystic fibrosis cells. Enzyme 1988; 40: 45-50.
32. Shapiro BL. Evidence for mitochondrial lesion in cystic fibrosis. Life Sci 1989; 44: 1327-1334.
33. Selvadurai HC, McKay K, Blimkie CJ, Cooper P, Mellis C, Van Aspen P. The relationship between genotype and exercise tolerance in children with cystic fibrosis. Am J Respir Crit Care Med 2002; 165: 762-765.
34. Hussey J, Gormley J, Leen G, Greally P. Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros 2002; 1: 116-121.
35. Elkin SL, Williams L, Moore M, Hodson M, Rutherford OM. Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. Clin Sci 2000; 99: 309-314.
36. Marcotte JE, Canny GJ, Grisdale R, et al. Effects of nutritional status on exercise performance in advanced cystic fibrosis. Chest 1986; 90: 375-379.
37. Boas SR, Joswiak ML, Nixon PA, Fulton JA, Orenstein DM. Factors limiting anaerobic performance in adolescent males with cystic fibrosis. Med Sci Sports Exer 1996; 28: 291-298.
38. Boucher GP, Lands L, Hay JA, Hornby L. Activity levels and relationship to lung function and nutritional status in children with cystic fibrosis. Am J Phys Med Rehab 1997; 76: 311-315.
39. Nixon PA, Orenstein DM, Kelsey SF. Habitual activity in children and adolescents with cystic fibrosis. Med Sci Sports Exer 2001; 33: 30-35.
40. O'Neill PA, Dodds M, Phillips B, Poole J, Webb AK. Regular exercise and reduction of breathlessness in patients with cystic fibrosis. Br J Dis Chest 1987; 81: 62-69.
41. De Jong W, van der Schans CP, Mannes GP, van Aalderen WM, Grevink RG, Koeter GH. Relationship between dyspnoea, pulmonary function and exercise capacity in patients with cystic fibrosis. Respir Med 1997; 91: 41-46.
42. Hamilton AL, Killian KJ, Summers E, Jones NL. Symptom intensity and subjective limitation to exercise in patients with cardiorespiratory disorders. Chest 1996; 110: 1255-1263.